InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Reid Laurence, Chairman & CEO. Director active across 1 company, notably Decibel Therapeutics, Inc.. Cumulatively, 4 filings have been logged. Split: 2 buys · 0 sell. Total volume traded: €129k. Activity tracked since 15 September 2021. The latest transaction was disclosed on 16 March 2023 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations
Laurence Reid is the President and Chief Executive Officer of Decibel Therapeutics, Inc. He is responsible for the strategic and operational direction of the company, which focuses on developing hearing treatments. Reid is committed to advancing Decibel's mission.